MyAverix Finance
SA · Healthcare
Revvity, Inc. (R1VT34)
Diagnostics & Research
Revvity, Inc. (R1VT34) is listed on SA in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $50.09B, P/E ratio is 41.03, net margin is 8.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R1VT34
Revvity, Inc. (R1VT34) — FAQ
What is Revvity, Inc.'s market cap?
Revvity, Inc. (R1VT34) has a reported market cap of $50.09B (data as of 2026-03-29).
What is R1VT34's P/E ratio?
The price-to-earnings (P/E) ratio for Revvity, Inc. (R1VT34) is 41.03 (data as of 2026-03-29).
Does Revvity, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Revvity, Inc. (R1VT34). Check the MyAverix Finance app for the latest dividend data.
What sector is Revvity, Inc. in?
Revvity, Inc. (R1VT34) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is R1VT34 listed on?
R1VT34 is listed on SA.
What is Revvity, Inc.'s net margin?
Revvity, Inc. (R1VT34) reports a net margin of 8.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.